Robert Bradley

Robert Bradley is a leading computational biologist studying alternative splicing dysregulation in cancer, developing algorithms to detect cancer-specific splicing events from large-scale RNA-seq datasets. His laboratory has identified thousands of tumor-specific splice isoforms that generate novel protein products and potential neoantigens. He has contributed to understanding how mutations in splicing factors globally alter the cancer transcriptome. His computational tools are widely used for splicing quantification in cancer genomics studies.